OIC Launches Intramedullary Tibial Nail

Tuesday, January 24, 2017 General News
Email Print This Page Comment
Font : A-A+

RENO, Nev., Jan. 24, 2017 /PRNewswire/ -- The Orthopaedic Implant Company (OIC), a medical device company that specializes

in high-value orthopaedic implants, announced the launch of its Tibial Intramedullary Nailing System today.

The OIC Tibial Nail System is designed to stabilize fractures of the tibia. Strategically placed proximal and distal screw holes accommodate

varying fracture patterns with a proximally-placed slotted hole that allows dynamization.  The nail is available in diameters of 9mm through 11.5mm and lengths of 280mm to 420mm and features 5.0mm diameter cross-lock screws for optimal implant fixation.

The OIC Tibial Nail is part of OIC's high value IM Nail System and uses the same instrumentation as all IM nails from OIC – decreasing inventory burdens and costs while increasing intra-operative efficiencies.  It is the third nail released in the last twelve months from the company that address long bone fractures. "We are very proud to offer the addition of the OIC Tibial Nail to our high value implant portfolio," said Todd Martens, VP of Product Design and Customer Experience. "We've designed the entire IM Nail System to meet the demands of value based healthcare; a rapidly growing trend."

About Orthopaedic Implant Company: OIC entered the medical device market in 2010 with an innovative approach to delivering the highest quality implants at the lowest possible prices. OIC implants cost 50 to 60 percent less than the average market price of premium implants, saving health care systems millions of dollars a year. OIC's high-quality, low-cost implants and products can be used for a variety of procedures, including treatment of orthopaedic trauma and spinal injuries.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oic-launches-intramedullary-tibial-nail-300395732.html

SOURCE The Orthopaedic Implant Company



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook